DIAMEDICA THERAPEUTICS INC
DMAC·25253X207·US·Common Stock·Healthcare - Biotechnology-13D/G
DMAC (DIAMEDICA THERAPEUTICS INC) is held by 64 institutional investors as of Q1 2026. Largest holders: COOPERMAN LEON G ($13.7M), BlackRock, Inc. ($12.6M), MILLENNIUM MANAGEMENT LLC ($6.3M). Net institutional sentiment: Mixed.
64
Holders
Avg rating(16 Elite)
$65.1M
Total Value
52% (73)
Fund Consensus
34 buying - 31 selling
Who's Trading
ActivistDLDialectic Life Sciences SPV LLC0.0%Feb 17, 2026
ActivistTATRILL AB16.9%Feb 6, 2026
InsiderSJSTAHLBERG JANBuy $627KNov 25, 2025
InsiderSJSTAHLBERG JANBuy $318KNov 24, 2025
InsiderSJSTAHLBERG JANBuy $1.5MNov 21, 2025
InsiderSJSTAHLBERG JANBuy $951KNov 20, 2025
InsiderSJSTAHLBERG JANBuy $1.7MNov 19, 2025
InsiderSJSTAHLBERG JANBuy $1.2MNov 18, 2025
InsiderSJSTAHLBERG JANBuy $1.2MNov 17, 2025
13F: Insider & Congress:
Showing 1-20 of 73
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer